AKT1 and hepatocellular carcinoma: Another study demonstrated that p16INK4A reactivation downregulated the expression of survivin, a crucial apoptotic regulator, and exhibited antitumor potency by downregulating AKt/survivin signaling in hepatocellular carcinoma cells37.